Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (2023) Vol. 382, Iss. 6666
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 764
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 145
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
Peter V. Markov, Aris Katzourakis, Nikolaos I. Stilianakis
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 251-252
Open Access | Times Cited: 136
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
Spyros Chalkias, Frank Eder, Brandon Essink, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2388-2397
Open Access | Times Cited: 128
Towards SARS-CoV-2 serotypes?
Etienne Simon‐Lorière, Olivier Schwartz
Nature Reviews Microbiology (2022) Vol. 20, Iss. 4, pp. 187-188
Open Access | Times Cited: 104
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
Karlijn van der Straten, Denise Guerra, Marit J. van Gils, et al.
Immunity (2022) Vol. 55, Iss. 9, pp. 1725-1731.e4
Open Access | Times Cited: 86
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 86
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
Anna Z. Mykytyn, Miruna E. Rosu, Adinda Kok, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e294-e295
Open Access | Times Cited: 56
Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023
Lara M. Jeworowski, Barbara Mühlemann, Felix Walper, et al.
Eurosurveillance (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 56
Population immunity predicts evolutionary trajectories of SARS-CoV-2
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5151-5164.e13
Open Access | Times Cited: 50
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access | Times Cited: 2
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 12, pp. 1745-1758.e7
Open Access | Times Cited: 61
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 44
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2334-2346
Open Access | Times Cited: 34
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
David Niklas Springer, Michael Bauer, Iris Medits, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 11
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
Barbara Mühlemann, Jakob Trimpert, Felix Walper, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Open Access | Times Cited: 10
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access | Times Cited: 1
Classification of five SARS-CoV-2 serotypes based on RBD antigenicities
Shixiong Hu, Chunli Wu, Xinkai Wu, et al.
Science Bulletin (2023) Vol. 68, Iss. 23, pp. 3003-3012
Open Access | Times Cited: 18
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Allison J. Greaney, Rachel Eguia, Tyler N. Starr, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010592-e1010592
Open Access | Times Cited: 25
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 5
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
Mehdi Benlarbi, Shilei Ding, Étienne Bélanger, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top